Parkside Financial Bank & Trust’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24K Sell
167
-15
-8% -$158 ﹤0.01% 2279
2025
Q4
$2.14K Buy
182
+15
+9% +$162 ﹤0.01% 2073
2025
Q3
$1.29K Buy
167
+73
+78% +$511 ﹤0.01% 2178
2025
Q2
$688 Buy
+94
New +$759 ﹤0.01% 2389
2025
Q1
Sell
-18
Closed -$297 2752
2024
Q4
$297 Buy
18
+1
+6% +$16 ﹤0.01% 1981
2024
Q3
$251 Hold
17
﹤0.01% 1970
2024
Q2
$236 Hold
17
﹤0.01% 1915
2024
Q1
$268 Hold
17
﹤0.01% 1872
2023
Q4
$276 Buy
17
+7
+70% +$115 ﹤0.01% 1862
2023
Q3
$123 Sell
10
-6
-38% -$89 ﹤0.01% 2012
2023
Q2
$258 Sell
16
-190
-92% -$3.13K ﹤0.01% 1951
2023
Q1
$3.59K Buy
206
+61
+42% +$869 ﹤0.01% 1487
2022
Q4
$1.34K Sell
145
-720
-83% -$6.71K ﹤0.01% 1783
2022
Q3
$7K Sell
865
-43
-5% -$427 ﹤0.01% 1108
2022
Q2
$7K Buy
908
+410
+82% +$3.91K ﹤0.01% 1120
2022
Q1
$6K Buy
498
+322
+183% +$6.78K ﹤0.01% 1230
2021
Q4
$6K Sell
176
-194
-52% -$7.6K ﹤0.01% 1240
2021
Q3
$18K Buy
370
+40
+12% +$1.85K 0.01% 808
2021
Q2
$15K Buy
330
+29
+10% +$1.28K ﹤0.01% 853
2021
Q1
$15K Hold
301
﹤0.01% 833
2020
Q4
$16K Buy
301
+184
+157% +$8.31K 0.01% 777
2020
Q3
$4K Buy
117
+14
+14% +$520 ﹤0.01% 986
2020
Q2
$3K Hold
103
﹤0.01% 1082
2020
Q1
$3K Hold
103
﹤0.01% 1019
2019
Q4
$3K Hold
103
﹤0.01% 1077
2019
Q3
$2K Hold
103
﹤0.01% 1187
2019
Q2
$2K Hold
103
﹤0.01% 1193
2019
Q1
$2K Buy
+103
New +$1.79K ﹤0.01% 1183

Other funds holding NEO

Parkside Financial Bank & Trust's NEO Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its NeoGenomics (NEO) stake by 8.2% in Q1 2026, selling an estimated $158 and leaving 167 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2279.

Parkside Financial Bank & Trust first reported a position in NEO in Q1 2019 and has held it in 28 quarters since. The position peaked at $18K in Q3 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Parkside Financial Bank & Trust held 167 shares of NeoGenomics worth $1.24K as of Q1 2026.
  • Parkside Financial Bank & Trust sold 15 NeoGenomics shares in Q1 2026, an estimated $158.
  • NeoGenomics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2279 holding.
  • Parkside Financial Bank & Trust first reported a position in NeoGenomics in Q1 2019 and has held it in 28 quarters since.
  • Parkside Financial Bank & Trust's NeoGenomics position peaked at $18K in Q3 2021.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.